Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins
- 1 July 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (1), 87-93
- https://doi.org/10.1182/blood-2002-08-2369
Abstract
Suppression of red blood cell production is a common complication of chemotherapy, causing anemia in a significant number of cancer patients. We have evaluated the sensitivity of human hematopoietic progenitors and erythroid precursor cells to chemotherapeutic drugs and found that probasophilic erythroblasts represent the stage of erythroid differentiation more vulnerable to the cytotoxic effects of myelosuppressive agents. Stem cell factor (SCF) supports proliferation and survival of early hematopoietic cells by binding to the c-kit receptor. In unilineage erythropoietic culture of CD34 + progenitors, short-term pretreatment of immature erythroid precursors with SCF results in protection from apoptosis induced by chemotherapeutic agents and restores normal proliferation and differentiation after removal of the cytotoxic stimulus. The levels of drug-induced caspase processing are significantly reduced in erythroblasts treated with SCF, indicating that activation of the c-kit receptor generates antiapoptotic signals acting before amplification of the caspase cascade. Accordingly, we found that SCF up-regulates Bcl-2 and Bcl-X L in erythroid precursors and that exogenous expression of these proteins protects erythroblasts from caspase activation and death induced by chemotherapeutic agents. These results suggest a possible mechanism for SCF-mediated protection of erythroid precursor cells from apoptosis and may contribute to devise new strategies for prevention and treatment of chemotherapy-induced anemia. (Blood. 2003; 102:87-93)Keywords
This publication has 52 references indexed in Scilit:
- Unilineage hematopoietic differentiation in bulk and single cell cultureThe International Journal of Cell Cloning, 2009
- Fibroblast Growth Factor-2 Induces Translational Regulation of Bcl-XL and Bcl-2 via a MEK-dependent PathwayJournal of Biological Chemistry, 2002
- Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinThe New England Journal of Medicine, 2002
- Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapyBlood, 2001
- Integrative Signaling by Minimal Erythropoietin Receptor Forms and c-KitPublished by Elsevier BV ,2001
- Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplatinum chemotherapyBritish Journal of Clinical Pharmacology, 2000
- Cisplatin-associated anemia: an erythropoietin deficiency syndrome.JCI Insight, 1995
- Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptorCell, 1990
- "Pure" Human Hematopoietic Progenitors: Permissive Action of Basic Fibroblast Growth FactorScience, 1990
- Decreased Erythropoietin Response in Patients with the Anemia of CancerThe New England Journal of Medicine, 1990